Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Subspecialty Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • Subspecialty Collections
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

The Biology Behind

  • The Biology Behind
    Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage
    F. Stephen Hodi
    Clin Cancer Res February 1 2006 12 (3) 673-678; DOI:10.1158/1078-0432.CCR-05-2616

Review

  • Review
    Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway
    Courtney A. Granville, Regan M. Memmott, Joell J. Gills and Phillip A. Dennis
    Clin Cancer Res February 1 2006 12 (3) 679-689; DOI:10.1158/1078-0432.CCR-05-1654

Human Cancer Biology

  • Human Cancer Biology
    Expression Profiling of Mucinous Tumors of the Ovary Identifies Genes of Clinicopathologic Importance
    Fred W. Wamunyokoli, Tomas Bonome, Ji-Young Lee, Colleen M. Feltmate, William R. Welch, Mike Radonovich, Cindy Pise-Masison, John Brady, Ke Hao, Ross S. Berkowitz, Samuel Mok and Michael J. Birrer
    Clin Cancer Res February 1 2006 12 (3) 690-700; DOI:10.1158/1078-0432.CCR-05-1110

  • Human Cancer Biology
    Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
    Robbert J.C. Slebos, Yajun Yi, Kim Ely, Jesse Carter, Amy Evjen, Xueqiong Zhang, Yu Shyr, Barbara M. Murphy, Anthony J. Cmelak, Brian B. Burkey, James L. Netterville, Shawn Levy, Wendell G. Yarbrough and Christine H. Chung
    Clin Cancer Res February 1 2006 12 (3) 701-709; DOI:10.1158/1078-0432.CCR-05-2017

  • Human Cancer Biology
    Molecular Context of the EGFR Mutations: Evidence for the Activation of mTOR/S6K Signaling
    Esther Conde, Barbara Angulo, Moying Tang, Manuel Morente, Juan Torres-Lanzas, Angel Lopez-Encuentra, Fernando Lopez-Rios and Montserrat Sanchez-Cespedes
    Clin Cancer Res February 1 2006 12 (3) 710-717; DOI:10.1158/1078-0432.CCR-05-1362

  • Human Cancer Biology
    Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma
    Julia S. Schleypen, Nicole Baur, Robert Kammerer, Peter J. Nelson, Karl Rohrmann, Elisabeth F. Gröne, Markus Hohenfellner, Axel Haferkamp, Heike Pohla, Dolores J. Schendel, Christine S. Falk and Elfriede Noessner
    Clin Cancer Res February 1 2006 12 (3) 718-725; DOI:10.1158/1078-0432.CCR-05-0857

  • Human Cancer Biology
    ZAP-70 Expression in Normal Pro/Pre B Cells, Mature B Cells, and in B-Cell Acute Lymphoblastic Leukemia
    Marta Crespo, Neus Villamor, Eva Giné, Ana Muntañola, Dolors Colomer, Teresa Marafioti, Margaret Jones, Mireia Camós, Elias Campo, Emili Montserrat and Francesc Bosch
    Clin Cancer Res February 1 2006 12 (3) 726-734; DOI:10.1158/1078-0432.CCR-05-1531

  • Human Cancer Biology
    Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A2–Dependent Prostaglandin E2 Generation in Human Colorectal Cancer Cells
    Gabriella D'Orazi, Maria Gina Sciulli, Valeria Di Stefano, Sabrina Riccioni, Milo Frattini, Rita Falcioni, Lucio Bertario, Ada Sacchi and Paola Patrignani
    Clin Cancer Res February 1 2006 12 (3) 735-741; DOI:10.1158/1078-0432.CCR-05-1557

  • Human Cancer Biology
    Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma
    Liu-Ying Luo, Shannon J.C. Shan, Marc B. Elliott, Antoninus Soosaipillai and Eleftherios P. Diamandis
    Clin Cancer Res February 1 2006 12 (3) 742-750; DOI:10.1158/1078-0432.CCR-05-1696

  • Human Cancer Biology
    A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
    Pasi A. Jänne, Ana M. Borras, Yanan Kuang, Andrew M. Rogers, Victoria A. Joshi, Hema Liyanage, Neal Lindeman, Jeffrey C. Lee, Balazs Halmos, Elizabeth A. Maher, Robert J. Distel, Matthew Meyerson and Bruce E. Johnson
    Clin Cancer Res February 1 2006 12 (3) 751-758; DOI:10.1158/1078-0432.CCR-05-2047

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    The GNAS1 T393C Polymorphism Predicts Survival in Patients with Clear Cell Renal Cell Carcinoma
    Ulrich H. Frey, Gerd Lümmen, Tobias Jäger, Karl-Heinz Jöckel, Kurt W. Schmid, Herbert Rübben, Norbert Müller, Winfried Siffert and Andreas Eisenhardt
    Clin Cancer Res February 1 2006 12 (3) 759-763; DOI:10.1158/1078-0432.CCR-05-1722

  • Imaging, Diagnosis, Prognosis
    Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
    Catherine Barrow, Judy Browning, Duncan MacGregor, Ian D. Davis, Sue Sturrock, Achim A. Jungbluth and Jonathan Cebon
    Clin Cancer Res February 1 2006 12 (3) 764-771; DOI:10.1158/1078-0432.CCR-05-1544

  • Imaging, Diagnosis, Prognosis
    The Cytogenetic Relationship between Primary and Recurrent Meningiomas Points to the Need for New Treatment Strategies in Cases at High Risk of Relapse
    Ana Belén Espinosa, María Dolores Tabernero, Angel Maíllo, José María Sayagués, Juana Ciudad, Marta Merino, Maria Carmen Alguero, Anne Marie Lubombo, Pablo Sousa, Angel Santos-Briz and Alberto Orfao
    Clin Cancer Res February 1 2006 12 (3) 772-780; DOI:10.1158/1078-0432.CCR-05-1480

  • Imaging, Diagnosis, Prognosis
    Molecular Subtyping of Breast Cancer from Traditional Tumor Marker Profiles Using Parallel Clustering Methods
    Federico Ambrogi, Elia Biganzoli, Patrizia Querzoli, Stefano Ferretti, Patrizia Boracchi, Saverio Alberti, Ettore Marubini and Italo Nenci
    Clin Cancer Res February 1 2006 12 (3) 781-790; DOI:10.1158/1078-0432.CCR-05-0763

  • Imaging, Diagnosis, Prognosis
    Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling
    Ben Davidson, Virginia Espina, Seth M. Steinberg, Vivi Ann Flørenes, Lance A. Liotta, Gunnar B. Kristensen, Claes G. Tropé, Aasmund Berner and Elise C. Kohn
    Clin Cancer Res February 1 2006 12 (3) 791-799; DOI:10.1158/1078-0432.CCR-05-2516

  • Imaging, Diagnosis, Prognosis
    Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D
    Yasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, Koichiro Nomata, Yasushi Hayashida, Jiro Eguchi, Tomayoshi Hayashi and Hiroshi Kanetake
    Clin Cancer Res February 1 2006 12 (3) 800-806; DOI:10.1158/1078-0432.CCR-05-1284

  • Imaging, Diagnosis, Prognosis
    Plasma Levels of Trefoil Factors are Increased in Patients with Advanced Prostate Cancer
    Else Marie Vestergaard, Michael Borre, Steen Seier Poulsen, Ebba Nexø and Niels Tørring
    Clin Cancer Res February 1 2006 12 (3) 807-812; DOI:10.1158/1078-0432.CCR-05-1545

  • Imaging, Diagnosis, Prognosis
    Optical Coherence Tomography: Real-time Imaging of Bronchial Airways Microstructure and Detection of Inflammatory/Neoplastic Morphologic Changes
    Suzanne C. Whiteman, Ying Yang, Daniel Gey van Pittius, Mark Stephens, Jitendra Parmer and Monica A. Spiteri
    Clin Cancer Res February 1 2006 12 (3) 813-818; DOI:10.1158/1078-0432.CCR-05-0245

  • Imaging, Diagnosis, Prognosis
    Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy
    Holly K. Dressman, Christopher Hans, Andrea Bild, John A. Olson, Eric Rosen, P. Kelly Marcom, Vlayka B. Liotcheva, Ellen L. Jones, Zeljko Vujaskovic, Jeffrey Marks, Mark W. Dewhirst, Mike West, Joseph R. Nevins and Kimberly Blackwell
    Clin Cancer Res February 1 2006 12 (3) 819-826; DOI:10.1158/1078-0432.CCR-05-1447

  • Imaging, Diagnosis, Prognosis
    Diffuse Mesothelin Expression Correlates with Prolonged Patient Survival in Ovarian Serous Carcinoma
    M. Jim Yen, Chih-Yi Hsu, Tsui-Lien Mao, T-C. Wu, Richard Roden, Tian-Li Wang and Ie-Ming Shih
    Clin Cancer Res February 1 2006 12 (3) 827-831; DOI:10.1158/1078-0432.CCR-05-1397

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    A Phase II Trial of Pemetrexed in Advanced Breast Cancer: Clinical Response and Association with Molecular Target Expression
    Henry L. Gomez, Sergio L. Santillana, Carlos S. Vallejos, Raul Velarde, Juvenal Sanchez, Xinpeng Wang, Nancy L. Bauer, Richard D. Hockett, Victor J. Chen, Clet Niyikiza and Axel R. Hanauske
    Clin Cancer Res February 1 2006 12 (3) 832-838; DOI:10.1158/1078-0432.CCR-05-0295

  • Cancer Therapy: Clinical
    Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib
    Gregory J. Riely, William Pao, DuyKhanh Pham, Allan R. Li, Naiyer Rizvi, Ennapadam S. Venkatraman, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi and Vincent A. Miller
    Clin Cancer Res February 1 2006 12 (3) 839-844; DOI:10.1158/1078-0432.CCR-05-1846

  • Cancer Therapy: Clinical
    Herceptin Sensitizes ErbB2–Overexpressing Cells to Apoptosis by Reducing Antiapoptotic Mcl-1 Expression
    Elizabeth S. Henson, Xiaojie Hu and Spencer B. Gibson
    Clin Cancer Res February 1 2006 12 (3) 845-853; DOI:10.1158/1078-0432.CCR-05-0754

  • Cancer Therapy: Clinical
    mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel Chemotherapy
    Henrik Gréen, Peter Söderkvist, Per Rosenberg, György Horvath and Curt Peterson
    Clin Cancer Res February 1 2006 12 (3) 854-859; DOI:10.1158/1078-0432.CCR-05-0950

  • Cancer Therapy: Clinical
    Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
    David A. Reardon, Jennifer A. Quinn, James J. Vredenburgh, Sridharan Gururangan, Allan H. Friedman, Annick Desjardins, Sith Sathornsumetee, James E. Herndon II, Jeannette M. Dowell, Roger E. McLendon, James M. Provenzale, John H. Sampson, Robert P. Smith, Alan J. Swaisland, Judith S. Ochs, Peggy Lyons, Sandy Tourt-Uhlig, Darell D. Bigner, Henry S. Friedman and Jeremy N. Rich
    Clin Cancer Res February 1 2006 12 (3) 860-868; DOI:10.1158/1078-0432.CCR-05-2215

  • Cancer Therapy: Clinical
    Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma
    Bruce E. Loveland, Anne Zhao, Shane White, Hui Gan, Kate Hamilton, Pei-Xiang Xing, Geoffrey A. Pietersz, Vasso Apostolopoulos, Hilary Vaughan, Vaios Karanikas, Peter Kyriakou, Ian F.C. McKenzie and Paul L.R. Mitchell
    Clin Cancer Res February 1 2006 12 (3) 869-877; DOI:10.1158/1078-0432.CCR-05-1574

  • Cancer Therapy: Clinical
    Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
    Scott J. Antonia, Noweeda Mirza, Ingo Fricke, Alberto Chiappori, Patricia Thompson, Nicholas Williams, Gerold Bepler, George Simon, William Janssen, Ji-Hyun Lee, Kerstin Menander, Sunil Chada and Dmitry I. Gabrilovich
    Clin Cancer Res February 1 2006 12 (3) 878-887; DOI:10.1158/1078-0432.CCR-05-2013

  • Cancer Therapy: Clinical
    A Metabolic Study of Patients with Lung Cancer and Hyponatremia of Malignancy
    John P. Chute, Elizabeth Taylor, John Williams, Frederic Kaye, David Venzon and Bruce E. Johnson
    Clin Cancer Res February 1 2006 12 (3) 888-896; DOI:10.1158/1078-0432.CCR-05-1536

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
    Jeffrey P. Norenberg, Boudewijn J. Krenning, Inge R.H.M. Konings, Donna F. Kusewitt, Tapan K. Nayak, Tamara L. Anderson, Marion de Jong, Kayhan Garmestani, Martin W. Brechbiel and Larry K. Kvols
    Clin Cancer Res February 1 2006 12 (3) 897-903; DOI:10.1158/1078-0432.CCR-05-1264

  • Cancer Therapy: Preclinical
    Strategies for Delaying or Treating In vivo Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
    Jeanne M. du Manoir, Giulio Francia, Shan Man, Miriam Mossoba, Jeffrey A. Medin, Alicia Viloria-Petit, Daniel J. Hicklin, Urban Emmenegger and Robert S. Kerbel
    Clin Cancer Res February 1 2006 12 (3) 904-916; DOI:10.1158/1078-0432.CCR-05-1109

  • Cancer Therapy: Preclinical
    Tumor Vascular Permeabilization by Vascular-Targeting Photosensitization: Effects, Mechanism, and Therapeutic Implications
    Bin Chen, Brian W. Pogue, Jorge M. Luna, Rulon L. Hardman, P. Jack Hoopes and Tayyaba Hasan
    Clin Cancer Res February 1 2006 12 (3) 917-923; DOI:10.1158/1078-0432.CCR-05-1673

  • Cancer Therapy: Preclinical
    The Schedule-Dependent Effects of the Novel Antifolate Pralatrexate and Gemcitabine Are Superior to Methotrexate and Cytarabine in Models of Human Non-Hodgkin's Lymphoma
    Lorraine E. Toner, Radovan Vrhovac, Emily A. Smith, Jeffrey Gardner, Mark Heaney, Mithat Gonen, Julie Teruya-Feldstein, Frank Sirotnak and Owen A. O'Connor
    Clin Cancer Res February 1 2006 12 (3) 924-932; DOI:10.1158/1078-0432.CCR-05-0331

  • Cancer Therapy: Preclinical
    Lovastatin Protects Human Endothelial Cells from Killing by Ionizing Radiation without Impairing Induction and Repair of DNA Double-Strand Breaks
    Tobias Nübel, Julia Damrot, Wynand P. Roos, Bernd Kaina and Gerhard Fritz
    Clin Cancer Res February 1 2006 12 (3) 933-939; DOI:10.1158/1078-0432.CCR-05-1903

  • Cancer Therapy: Preclinical
    Histone Deacetylase Inhibitor–Mediated Radiosensitization of Human Cancer Cells: Class Differences and the Potential Influence of p53
    In Ah Kim, Jin Hee Shin, Il Han Kim, Jin Ho Kim, Jae Sung Kim, Hong Gyun Wu, Eui Kyu Chie, Sung Whan Ha, Charn Il Park and Gary D. Kao
    Clin Cancer Res February 1 2006 12 (3) 940-949; DOI:10.1158/1078-0432.CCR-05-1230

  • Cancer Therapy: Preclinical
    BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways
    Jinming Yang, Katayoun I. Amiri, James R. Burke, Johannes A. Schmid and Ann Richmond
    Clin Cancer Res February 1 2006 12 (3) 950-960; DOI:10.1158/1078-0432.CCR-05-1220

Cancer Prevention

  • Cancer Prevention
    Risk Stratification of Colon Carcinogenesis through Enhanced Backscattering Spectroscopy Analysis of the Uninvolved Colonic Mucosa
    Hemant K. Roy, Young L. Kim, Yang Liu, Ramesh K. Wali, Michael J. Goldberg, Vladimir Turzhitsky, Jonathan Horwitz and Vadim Backman
    Clin Cancer Res February 1 2006 12 (3) 961-968; DOI:10.1158/1078-0432.CCR-05-1605

  • Cancer Prevention
    Chemoprevention of Skin Carcinogenesis by Phenylretinamides: Retinoid Receptor–Independent Tumor Suppression
    Hui Xu, Satish Cheepala, Elisabeth McCauley, Kevin Coombes, Lianchun Xiao, Susan M. Fischer and John L. Clifford
    Clin Cancer Res February 1 2006 12 (3) 969-979; DOI:10.1158/1078-0432.CCR-05-1648

  • Cancer Prevention
    2-Methoxyestradiol Inhibits Prostate Tumor Development in Transgenic Adenocarcinoma of Mouse Prostate: Role of Tumor Necrosis Factor-α–Stimulated Gene 6
    Gretchen E. Garcia, Hans-Georg Wisniewski, M. Scott Lucia, Nicole Arevalo, Thomas J. Slaga, Susan L. Kraft, Robert Strange and Addanki P. Kumar
    Clin Cancer Res February 1 2006 12 (3) 980-988; DOI:10.1158/1078-0432.CCR-05-2068

  • Cancer Prevention
    High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk
    Takao Maekita, Kazuyuki Nakazawa, Mami Mihara, Takeshi Nakajima, Kimihiko Yanaoka, Mikitaka Iguchi, Kenji Arii, Atsushi Kaneda, Tetsuya Tsukamoto, Masae Tatematsu, Gen Tamura, Daizo Saito, Takashi Sugimura, Masao Ichinose and Toshikazu Ushijima
    Clin Cancer Res February 1 2006 12 (3) 989-995; DOI:10.1158/1078-0432.CCR-05-2096

Correction

  • Correction
    Article on Quantification of Plasma β-catenin mRNA
    Clin Cancer Res February 1 2006 12 (3) 996-996; DOI:10.1158/1078-0432.CCR-12-3-COR

Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement
    Steven E. Come, Aman U. Buzdar, James N. Ingle, Carlos L. Arteaga, Myles Brown, Mitch Dowsett, Susan G. Hilsenbeck, Rakesh Kumar, Stephen R.D. Johnston, Adrian V. Lee, Soonmyung Paik, Kathleen I. Pritchard, Eric P. Winer and Carol Hart
    Clin Cancer Res February 1 2006 12 (3) 997s-1000s; DOI:10.1158/1078-0432.CCR-05-2268

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Novel Mechanisms of Resistance to Endocrine Therapy: Genomic and Nongenomic Considerations
    Anupama E. Gururaj, Suresh K. Rayala, Ratna K. Vadlamudi and Rakesh Kumar
    Clin Cancer Res February 1 2006 12 (3) 1001s-1007s; DOI:10.1158/1078-0432.CCR-05-2110

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors
    Incheol Shin, Todd Miller and Carlos L. Arteaga
    Clin Cancer Res February 1 2006 12 (3) 1008s-1012s; DOI:10.1158/1078-0432.CCR-05-2352

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer
    Hyun-Jung Kim, Xiaojiang Cui, Susan G. Hilsenbeck and Adrian V. Lee
    Clin Cancer Res February 1 2006 12 (3) 1013s-1018s; DOI:10.1158/1078-0432.CCR-05-2128

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Methods for Gene Expression Profiling in Clinical Trials of Adjuvant Breast Cancer Therapy
    Soonmyung Paik
    Clin Cancer Res February 1 2006 12 (3) 1019s-1023s; DOI:10.1158/1078-0432.CCR-05-2296

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Proliferation and Apoptosis as Markers of Benefit in Neoadjuvant Endocrine Therapy of Breast Cancer
    Mitch Dowsett, Ian E. Smith, Steve R. Ebbs, J. Michael Dixon, Anthony Skene, Clive Griffith, Irene Boeddinghaus, Janine Salter, Simone Detre, Margaret Hills, Susan Ashley, Stephen Francis, Geraldine Walsh and Roger A'Hern
    Clin Cancer Res February 1 2006 12 (3) 1024s-1030s; DOI:10.1158/1078-0432.CCR-05-2127

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Adjuvant Endocrine Therapy for Postmenopausal Women with Early Breast Cancer
    James N. Ingle
    Clin Cancer Res February 1 2006 12 (3) 1031s-1036s; DOI:10.1158/1078-0432.CCR-05-2122

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Anastrozole as an Adjuvant Endocrine Treatment for Postmenopausal Patients with Breast Cancer: Emerging Data
    Aman U. Buzdar and Jack Cuzick
    Clin Cancer Res February 1 2006 12 (3) 1037s-1048s; DOI:10.1158/1078-0432.CCR-05-2458

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Is There a Role for Adjuvant Tamoxifen in Progesterone Receptor–Positive Breast Cancer? An In silico Clinical Trial
    Susan G. Hilsenbeck and C. Kent Osborne
    Clin Cancer Res February 1 2006 12 (3) 1049s-1055s; DOI:10.1158/1078-0432.CCR-05-2123

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues
    Timothy J. Whelan and Kathleen I. Pritchard
    Clin Cancer Res February 1 2006 12 (3) 1056s-1060s; DOI:10.1158/1078-0432.CCR-05-2185

  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
    Clinical Efforts to Combine Endocrine Agents with Targeted Therapies against Epidermal Growth Factor Receptor/Human Epidermal Growth Factor Receptor 2 and Mammalian Target of Rapamycin in Breast Cancer
    Stephen R.D. Johnston
    Clin Cancer Res February 1 2006 12 (3) 1061s-1068s; DOI:10.1158/1078-0432.CCR-05-2125

Back to top
PreviousNext
Clinical Cancer Research: 12 (3)
February 2006
Volume 12, Issue 3
  • Table of Contents
  • About the Cover
  • Index by Author

Sign up for alerts

Jump to

  • The Biology Behind
  • Review
  • Human Cancer Biology
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Therapy: Preclinical
  • Cancer Prevention
  • Correction
  • Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Biomarkers for Adjuvant Sunitinib in Locoregional RCC
  • Targeting HER2 with Osimertinib in NSCLC
  • AZD5363 in Solid and PIK3CA-Mutated Cancers
  • Adjuvant Pazopanib in RCC: Exposure–Response Relationships
  • 16-Gene Recurrence Score in Locoregional, High-Risk RCC
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement